Citations

Clear

31 citation(s) found for "Sharma, Akanksha".

Clinical evaluation of fitness to drive in patients with brain metastases (P6.151)
Sánchez, Cristina Valencia, Gorelkin, Vanessa C, Vora, Sujay A., Ashman, Jonathan B. , Daniels, T.B., Halyard, Michele Y. , Rule, William G., Mrugala, Maciej , Porter, Alyx B. , Schild, Steven E. , Sharma, Akanksha

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p6.151 Get It

CASPR2 Autoimmunity Preceding the Diagnosis of Thyroid Cancer (P6.099)
López‐Chiriboga, A. Sebastian , Mrugała, Maciej M. , Sharma, Akanksha , McKeon, Andrew

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p6.099 Get It

Invasive Mucormycosis in an Immunocompetent Non-Diabetic with Severe Acidosis (P5.086)
Siv, Jenny, Schackmann, Elizabeth, Sharma, Akanksha , Davis, Arielle

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p5.086 Get It

Psychiatric Disturbance As a Presenting Symptom in Central Nervous System Lymphoma (P1.6-011)
Ertz-Archambault, Natalie , Mountjoy, Luke , Porter, Alyx B. , Mrugała, Maciej M. , Sharma, Akanksha

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.6-011 Get It

A Pilot Study to Assess the Integration of a Unique PROQOL Tool and Early Palliative Care Intervention in the Care of High Grade Glioma Patients and their Caregivers (2633)
Wolfe, Eric, Barrera, Celina, Williamson, Samantha, Farfour, Hannah , Mrugała, Maciej M. , Edwin, Mark, Sloan, Jeff A. , Porter, Alyx B. , Sharma, Akanksha

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.2633 Get It

Longitudinal Perception of Prognosis of Patients with High Grade Glioma Compared to their Caregivers and Clinicians (2588)
Wolfe, Eric, Barrera, Celina, Williamson, Samantha, Farfour, Hannah , Mrugała, Maciej M. , Edwin, Mark, Sloan, Jeff A. , Porter, Alyx B. , Sharma, Akanksha

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.2588 Get It

Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma
Thomson, Holly M, Ensign, Shannon P. Fortin , Edmonds, Victoria S. , Butterfield, Richard , Ashman, Jonathan B. , Zimmerman, Richard S. , Bryce, Alan H. , Vora, Sujay A., Porter, Alyx B. , Ensign, Shannon P. Fortin , Schild, Steven E. , Bryce, Alan H , Sharma, Akanksha , Patel, Naresh P. , Sio, Terence T.

Mayo Clinic

Clinical Medicine Insights: Oncology | March 21, 2023 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/11795549231161878 | PMID 36968334 Get It

Background: Radiation necrosis (RN) is a clinically relevant complication of stereotactic radiosurgery (SRS) for intracranial metastasis (ICM) treatments. Radiation necrosis development is variable following SRS. It remains unclear if risk factors for and clinical outcomes following RN may be different for melanoma patients. We reviewed patients with ICM from metastatic melanoma to understand the potential impact of RN in this patient population. Methods: Patients who received SRS for ICM from melanoma at Mayo Clinic Arizona between 2013 and 2018 were retrospectively reviewed. Data collected included demographics, tumor characteristics, radiation parameters, prior surgical and systemic treatments, and patient outcomes. Radiation necrosis was diagnosed by clinical evaluation including brain magnetic resonance imaging (MRI) and, in some cases, tissue evaluation. Results: Radiation necrosis was diagnosed in 7 (27%) of 26 patients at 1.6 to 38 months following initial SRS. Almost 92% of all patients received systemic therapy and 35% had surgical resection prior to SRS. Patients with RN trended toward having larger ICM and a prior history of surgical resection, although statistical significance was not reached. Among patients with resection, those who developed RN had a longer period between surgery and SRS start (mean 44 vs 33 days). Clinical improvement following treatment for RN was noted in 2 (29%) patients. Conclusions: Radiation necrosis is relatively common following SRS for treatment of ICM from metastatic melanoma and clinical outcomes are poor. Further studies aimed at mitigating RN development and identifying novel approaches for treatment are warranted.
QLTI-12. THE IMPACT OF MENTORING ON EARLY CAREER FACULTY: ASSESSMENT OF A VIRTUAL MENTORING PROGRAM
Molaie, Donna, Porter, Alyx B. , Sharma, Akanksha , Leeper, Heather , Bang, Soo‐Mee

Mayo Clinic

Neuro-Oncology | November 14, 2022 | Volume: 24 | Issue: Supplement_7 | Pages: vii237-vii237

10.1093/neuonc/noac209.914 Get It

Abstract BACKGROUND Participation in mentorship programs for early career physicians is crucial to developing key skills and professional networks, but availability and opportunities for mentorship may be hampered by racial, ethnic and gender leadership disparities in medicine. A 6-month virtually facilitated peer mentorship program for women and diverse early career faculty was developed and piloted through the Society for Neuro-Oncology (SNO) Women & Diversity Committee. METHODS We designed and conducted a 6-month pilot open to SNO’s multidisciplinary early career members, leveraging peer-mentoring sessions with mid-to late-career physician mentors. A curriculum with online resources was provided and group assignments were based on time-zones and interests. Pre- and post-participation surveys assessed mentee experience and descriptive statistics assessed participant demographics and survey results. Results/ CONCLUSION Twenty mentee applicants participated in 5 groups. Mentees were 90% women, 60% from diverse racial and ethnic backgrounds. Most were aged 31-40 (75%) and junior faculty (50%) in neuro-oncology (65%). Five mentors (2 female) practiced either neuro-oncology (3), neurosurgery (1) or radiation oncology (1). The proportion of mentees with a signature talk increased from 15% to 71% during the pilot. A large majority (64%) reported a positive impact of the program on their profile, career and networking, and reported participation was worthwhile (86%), and worth recommending to others (93%). Feedback themes included personal growth, peer support, networking, job opportunities, desire for late career female mentors, and scheduling constraints. The virtual environment during a global pandemic allowed participants to connect, creating a venue to discuss topics such as work-life balance, burnout, and self-advocacy. We did not have 100% post pilot follow up despite multiple attempts, limiting complete understanding of the pilot. This virtual mentorship pilot program proved feasible and of value in development of early career women and diverse individuals. A resource toolkit has been designed to scale and diffuse.
The impact of mentoring on early career faculty: Assessment of a virtual mentoring program.
Molaie, Donna, Porter, Alyx B. , Sharma, Akanksha , Leeper, Heather , Bang, Soo‐Mee

Mayo Clinic

Journal of Clinical Oncology | June 6, 2022 | Volume: 40 | Issue: 16_suppl | Pages: 11039-11039

10.1200/jco.2022.40.16_suppl.11039 Get It

11039 Background: Participation in mentorship programs for early career physicians may be crucial to developing key skills and professional networks to navigate racial, ethnic and gender leadership disparities in medicine. A 6-month virtual facilitated peer mentorship program was developed and piloted through the Society for Neuro-Oncology (SNO) Women & Diversity Committee. The evaluation of the program’s feasibility to positively impact early career physicians, investigators and trainees is presented here. Methods: We designed and conducted a virtual mentoring program pilot open to SNO’s multidisciplinary members in residency, fellowship, or early career phase, leveraging peer-mentoring sessions with mid-to late-career physician mentors. A curriculum with online resources was provided recommending groups meet for 6 sessions: 3 involving the mentor and 3 dedicated to peer-mentoring. Group assignments were based on time-zones and interests. Pre- and post-participation surveys assessed mentee experience. Descriptive statistics were used to assess participant demographics and survey results. Results: Our call for participation was broad; all 20 mentee applicants participated in 5 groups. Mentees were 90% women and 60% were from diverse racial and ethnic backgrounds. Most were aged 31-40 (75%) and junior faculty (50%) in neuro-oncology (65%). The 5 senior mentors (3 men and 3 of diverse race and ethnic backgrounds) practiced either neuro-oncology (3), neurosurgery (1) or radiation oncology (1). The proportion who reporting having a signature lecture increased from 15% to 62% during the pilot. A large majority reported their participation was worthwhile (85%), that they would participate again (92%) and would recommend it to others (92%). Feedback themes included positive personal growth, peer support, networking and job opportunities, access to CV reviews, lack of and desire for late career female mentors, and virtual scheduling constraints. While the pilot was limited by several variables, it was timely to connect participants in Q3 of 2020 early in the COVID-19 global pandemic. The virtual meeting environment created a venue to share and discuss topics such as work-life balance, burnout, leading through change and social connection. Despite not achieving 100% professional concordance, participants found the experience worthwhile. The tools and curriculum of topics provided was implemented differently across groups, leading to varied experiences. Finally, we did not have 100% post pilot follow up despite multiple attempts limiting our complete understanding of the pilot. Conclusions: This virtual mentorship pilot program proved feasible and of value in development of early career women and diverse individuals. A resource toolkit has been designed to scale and diffuse.
Rare adverse events following Covid-19 vaccination: A review
Barary, Mohammad , Afshar, Zeinab Mohseni , Liang, Jackson J. , Sharma, Akanksha , Hashemi, Erfan , Abdi, Sadaf, Allahgholipour, Amirreza , Hosseinzadeh, Rezvan , Vaziri, Zahra , Ebrahimpour, Soheil , Barary, Mohammad , Liang, Jackson , Afshar, Zeinab Mohseni , Pirzadeh, Marzieh , Babazadeh, Arefeh , Deravi, Niloofar , Sio, Terence T. , Sullman, Mark J. M.

Mayo Clinic

No container title available | March 31, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.164873369.97865492/v1 Get It

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused many complications, the invention of coronavirus disease 2019 (Covid-19) vaccines has also brought about several adverse events, from common side effects to unexpected and rare ones. Common vaccine-related adverse reactions manifest locally or systematically following any vaccine, including Covid-19 vaccines. Certain side effects, known as adverse events of special interest (AESI), are unusual and need more evaluation. Here, we discuss some of the most important rare adverse events of Covid-19 vaccines.